Piramal Pharma Limited announced that Ms. Nathalie Leitch has tendered her resignation from the position of Non-Executive, Non-Independent Director of the Company with immediate effect on account of other professional commitments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
149.6 INR | +1.73% | +0.03% | +7.71% |
May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.71% | 2.34B | |
+38.42% | 723B | |
+34.28% | 595B | |
-4.36% | 369B | |
+20.23% | 332B | |
+2.46% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.05% | 168B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Piramal Pharma Limited Announces Resignation of Nathalie Leitch as Non-Executive, Non-Independent Director